168 related articles for article (PubMed ID: 16110145)
1. Paul Ehrlich's "Mastzellen"--from aniline dyes to DNA chip arrays: a historical review of developments in mast cell research.
Vyas H; Krishnaswamy G
Methods Mol Biol; 2006; 315():3-11. PubMed ID: 16110145
[TBL] [Abstract][Full Text] [Related]
2. The history of the controversial relationship between mast cells and basophils.
Crivellato E; Nico B; Ribatti D
Immunol Lett; 2011 Dec; 141(1):10-7. PubMed ID: 21756940
[TBL] [Abstract][Full Text] [Related]
3. Paul Ehrlich's mastzellen: a historical perspective of relevant developments in mast cell biology.
Ghably J; Saleh H; Vyas H; Peiris E; Misra N; Krishnaswamy G
Methods Mol Biol; 2015; 1220():3-10. PubMed ID: 25388241
[TBL] [Abstract][Full Text] [Related]
4. Paul Ehrlich and the Early History of Granulocytes.
Kay AB
Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726791
[TBL] [Abstract][Full Text] [Related]
5. Mast cell ontogeny: an historical overview.
Ribatti D; Crivellato E
Immunol Lett; 2014; 159(1-2):11-4. PubMed ID: 24534641
[TBL] [Abstract][Full Text] [Related]
6. Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts.
Valent P; Akin C; Hartmann K; Nilsson G; Reiter A; Hermine O; Sotlar K; Sperr WR; Escribano L; George TI; Kluin-Nelemans HC; Ustun C; Triggiani M; Brockow K; Gotlib J; Orfao A; Kovanen PT; Hadzijusufovic E; Sadovnik I; Horny HP; Arock M; Schwartz LB; Austen KF; Metcalfe DD; Galli SJ
Theranostics; 2020; 10(23):10743-10768. PubMed ID: 32929378
[TBL] [Abstract][Full Text] [Related]
7. Paul Ehrlich's passion: the origins of his receptor immunology.
Silverstein AM
Cell Immunol; 1999 Jun; 194(2):213-21. PubMed ID: 10383824
[TBL] [Abstract][Full Text] [Related]
8. The discovery of aniline and the origin of the term "aniline dye".
Johnston WT
Biotech Histochem; 2008 Apr; 83(2):83-7. PubMed ID: 18568682
[TBL] [Abstract][Full Text] [Related]
9. Our perception of the mast cell from Paul Ehrlich to now.
Beaven MA
Eur J Immunol; 2009 Jan; 39(1):11-25. PubMed ID: 19130582
[TBL] [Abstract][Full Text] [Related]
10. Paul Ehrlich: pathfinder in cell biology. 1. Chronicle of his life and accomplishments in immunology, cancer research, and chemotherapy.
Kasten FH
Biotech Histochem; 1996 Jan; 71(1):2-37. PubMed ID: 9138526
[TBL] [Abstract][Full Text] [Related]
11. Paul Ehrlich's doctoral thesis: a milestone in the study of mast cells.
Crivellato E; Beltrami Ca; Mallardi F; Ribatti D
Br J Haematol; 2003 Oct; 123(1):19-21. PubMed ID: 14510938
[No Abstract] [Full Text] [Related]
12. The return of Ehrlich's 'Therapia magna sterilisans' and other Ehrlich concepts?. Series of papers honoring Paul Ehrlich on the occasion of his 150th birthday.
Sörgel F
Chemotherapy; 2004 Apr; 50(1):6-10. PubMed ID: 15084798
[TBL] [Abstract][Full Text] [Related]
13. [100 years of Dr. Ehrlich's magic bullet (1909-2009)].
García-Sánchez JE; García E; Merino ML
Enferm Infecc Microbiol Clin; 2010 Oct; 28(8):521-33. PubMed ID: 20097455
[TBL] [Abstract][Full Text] [Related]
14. Paul Ehrlich: pioneer of chemotherapy and cure by arsenic (1854-1915).
Thorburn AL
Br J Vener Dis; 1983 Dec; 59(6):404-5. PubMed ID: 6196079
[TBL] [Abstract][Full Text] [Related]
15. Dyes, antipsychotic drugs, and antimicrobial activity. Fragments of a development, with special reference to the influence of Paul Ehrlich.
Kristiansen JE
Dan Med Bull; 1989 Apr; 36(2):178-85. PubMed ID: 2651032
[TBL] [Abstract][Full Text] [Related]
16. The contribution of Paul Ehrlich to histochemistry: a tribute on the occasion of the centenary of his death.
Buchwalow I; Boecker W; Tiemann M
Virchows Arch; 2015 Jan; 466(1):111-6. PubMed ID: 25359602
[TBL] [Abstract][Full Text] [Related]
17. The use of dyes in modern biomedicine.
Wainwright M
Biotech Histochem; 2003; 78(3-4):147-55. PubMed ID: 14714878
[TBL] [Abstract][Full Text] [Related]
18. Chemical Modeling: From Paul Ehrlich's Dyes to
Travis AS
J Comput Biol; 2019 Jul; 26(7):726-734. PubMed ID: 31066580
[No Abstract] [Full Text] [Related]
19. [Paul Ehrlich's methods for deciphering the immune defence. One method leads only to an incomplete understanding].
Göing H
Arzneimittelforschung; 2000 Apr; 50(4):404-8. PubMed ID: 10800641
[TBL] [Abstract][Full Text] [Related]
20. [Paul Ehrlich (1854-1915) and his contacts with East European physicians at the time of testing the first chemioterapeutics].
Schneck P
Arch Hist Filoz Med; 1996; 59(1):41-8. PubMed ID: 11619177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
